As of 3:56pm ET
| +0.0003 / +0.07%|
The 1 analysts offering 12-month price forecasts for Cesca Therapeutics Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +250.14% increase from the last price of 0.43.
The current consensus among 1 polled investment analysts is to Buy stock in Cesca Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.